HCV-RNA levels play an important role independently of genotype in predicting response to interferon therapy

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 1, 1997, Pages 67-69

  Picciotto, Antonino ^a   Campo, Nadia ^a   Brizzolara, Renata ^a   Sinelli, Nicoletta ^a   Poggi, Giulia ^a   Grasso, Sandro ^b   Celle, Guido ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Savona Hospital   (Italy)

Author keywords

Chronic hepatitis C; HCV genotype; HCV RNA; Interferon; Viraemia level

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; VIRUS RNA;

ADULT; ARTICLE; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; VIREMIA;

EID: 0031035147     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199701000-00016     Document Type: Article

References (17)

1. Hoofnagle JH, Mullen KD, Jones DB, Rustgj V, DiBisceglie A, Waggoner JG, et al.: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 1986, 315:1575-1578.
2. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Carey W, et al.: Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. N Engl J Med 1989, 321:1501-1506.
3. DiBisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Goodman Z, et al.: Recombinant interferon alpha therapy for chronic hepatitis C: a randomized, double-blind placebo controlled trial. N Engl J Med 1989, 321:1506-1510.
4. Weiland O, Schvarz R, Wejstal R, Norkrans G, Fryden A: Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alpha-2b: Swedish experience. J Hepatol 1990, 11:S57-S62.
5. Marcellin P, Boyer N, Giostra E, Degott C, Courance AM, Coppere H, et al.: Recombinant human interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology 1991, 13:393-397.
6. Shindo M, DiBisceglie AM, Hoofnagle JH: Long-term follow-up of patients with chronic hepatitis C treated with alpha interferon. Hepatology 1992, 15: 1013-1016.
7. Tsubata A, Chayama K, Ikeda K, Yasuji A, Kaida I, Sailoh S, et al.: Factors predictive of response to interferon α-therapy in hepatitis C virus infection. Hepatology 1994, 19:1088-1094.
8. Kanai K, Kako M, Okamoto H: HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992, 339:1543.
9. Yoshioka K, Kakum S, Wakita T, Ishikavva T, Itoh Y, Takayanagi M, et al.: Detection of hepatitis C virus by polymerase chain reaction and response to interferon α-therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992, 16:293-299.
10. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, et al.: Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci 1994, 39:977-982.
11. Lau JYN, Davis GL, Kuiffen J, Qian KP, Urdea MS, Chan CS, et al.: Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993, 341:1501-1504.
12. Craxi' A, Magrin S, Fabiano C, Linea C, Almasio P: Host and viral features in chronic HCV infection: relevance to interferon responsiveness. Res Virol 1995, 146:273-278.
13. Shindo M, DiBisceglie AM, Cheung L, Shih WK, Cristiano K, Feinstone SM, et al.: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991, 115:700-704.
14. Yuki N, Hayashi N, Kasahara A, Hagiwara H, Takehara T, Oshita M, et al.: Pretreatment viral load and response to prolonged interferon a course for chronic hepatitis C. J Hepatol 1995, 22:457-463.
15. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Erlinger S, et al.: Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995, 22:1050-1056.
16. Conjeevaram HS, Everhart JE, Hoofnagle JH: Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995, 22:1326-1328.
17. Yamada G, Takatani M, Kishi F, Takahashi M, Doi T, Kolberg JA, et al.: Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 1995, 22:1351-1354.